US Stock MarketDetailed Quotes
AWH Aspira Women's Health
- 0.8511
- +0.0111+1.32%
Close Sep 13 16:00 ET
- 0.9100
- +0.0589+6.92%
Post 20:01 ET
13.67MMarket Cap-599P/E (TTM)
0.8911High0.8511Low49.84KVolume0.8620Open0.8400Pre Close43.53KTurnover0.46%Turnover RatioLossP/E (Static)16.06MShares6.099652wk High-3.68P/B9.27MFloat Cap0.810052wk Low--Dividend TTM10.89MShs Float1856.0553Historical High--Div YieldTTM4.76%Amplitude-115.7500Historical Low0.8730Avg Price1Lot Size
Aspira Women's Health Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -9.48%-3.74M | 22.34%-4.43M | 48.84%-15.89M | 51.24%-3.45M | 55.81%-3.32M | 45.80%-3.42M | 43.91%-5.71M | -13.41%-31.07M | 7.49%-7.08M | 6.07%-7.52M |
| Net income from continuing operations | -52.35%-3.53M | 29.63%-4.63M | 44.15%-16.69M | 32.72%-3.09M | 39.53%-4.71M | 71.89%-2.32M | 29.02%-6.58M | 5.61%-29.89M | 48.77%-4.59M | 19.82%-7.78M |
| Operating gains losses | 55.37%-889K | -1,145.83%-251K | 4.40%-1.63M | -84.19%-862K | 196.93%1.2M | -199,300.00%-1.99M | 1,100.00%24K | -69.55%-1.7M | ---468K | ---1.24M |
| Depreciation and amortization | -50.00%26K | -58.57%29K | -24.62%199K | -46.38%37K | -40.30%40K | -18.75%52K | 9.38%70K | -12.58%264K | 7.81%69K | 1.52%67K |
| Other non cash items | --0 | -400.00%-3K | -56.92%249K | ---7K | -101.57%-9K | 13,100.00%264K | -50.00%1K | 1,462.16%578K | --0 | 19,033.33%574K |
| Change In working capital | 476.09%530K | -90.53%36K | 108.04%225K | 100.70%18K | -185.48%-265K | -92.71%92K | 120.98%380K | -300.79%-2.8M | -490.24%-2.56M | -32.46%310K |
| -Change in receivables | 202.38%86K | 76.70%-72K | 1.83%-214K | 397.73%131K | 153.93%48K | -450.00%-84K | -183.49%-309K | -34.57%-218K | -157.89%-44K | -196.67%-89K |
| -Change in inventory | -66.67%10K | -164.29%-9K | 162.68%89K | 305.56%74K | 67.42%-29K | 1,600.00%30K | 193.33%14K | 1.39%-142K | 2.70%-36K | -147.22%-89K |
| -Change in prepaid assets | -43.75%324K | -82.97%55K | 1,648.48%577K | 34.34%-434K | -60.84%112K | 47.69%576K | 1,694.44%323K | 106.02%33K | 18.40%-661K | 425.00%286K |
| -Change in payables and accrued expense | 256.09%359K | -44.37%316K | 93.53%-159K | 117.45%315K | -501.98%-812K | -127.06%-230K | 133.31%568K | -209.34%-2.46M | -226.49%-1.81M | -67.05%202K |
| -Change in other current liabilities | -24.50%-249K | -17.59%-254K | -385.71%-68K | ---- | ---- | ---200K | ---216K | ---14K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -9.48%-3.74M | 22.34%-4.43M | 48.84%-15.89M | 51.24%-3.45M | 55.81%-3.32M | 45.80%-3.42M | 43.91%-5.71M | -13.41%-31.07M | 7.49%-7.08M | 6.07%-7.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -275.00%-15K | -150.00%-20K | 89.66%-24K | 83.78%-12K | 0 | 82.61%-4K | 90.24%-8K | -26.09%-232K | -146.67%-74K | -194.44%-53K |
| Net PPE purchase and sale | -275.00%-15K | -150.00%-20K | 89.66%-24K | 83.78%-12K | --0 | 82.61%-4K | 90.24%-8K | -26.09%-232K | -146.67%-74K | -194.44%-53K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -275.00%-15K | -150.00%-20K | 89.66%-24K | 83.78%-12K | --0 | 82.61%-4K | 90.24%-8K | -26.09%-232K | -146.67%-74K | -194.44%-53K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 679.85%1.05M | 9,680.00%5.27M | -29.77%5.22M | 1,122.34%961K | -45.33%4.18M | 379.17%134K | 21.43%-55K | -84.65%7.43M | -754.55%-94K | 5,132.19%7.64M |
| Net issuance payments of debt | 1,029.17%1.08M | 570.59%400K | 494.25%1.03M | 1,636.92%999K | 129.23%19K | 262.71%96K | -18.06%-85K | -31.82%-261K | -30.00%-65K | -32.65%-65K |
| Net common stock issuance | --0 | --0 | -97.76%202K | --0 | --0 | --40K | --162K | -81.34%9M | --0 | --9M |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -98.19%13K | --0 | --0 |
| Net other financing activities | -1,850.00%-39K | 3,788.64%4.87M | 400.75%3.99M | -31.03%-38K | --4.16M | ---2K | ---132K | -251.46%-1.33M | -3,000.00%-29K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 679.85%1.05M | 9,680.00%5.27M | -29.77%5.22M | 1,122.34%961K | -45.33%4.18M | 379.17%134K | 21.43%-55K | -84.65%7.43M | -754.55%-94K | 5,132.19%7.64M |
| Net cash flow | ||||||||||
| Beginning cash position | -52.84%3.67M | -78.94%2.86M | -63.78%13.56M | -74.25%5.36M | -78.29%4.5M | -71.27%7.79M | -63.78%13.56M | 125.06%37.43M | -53.90%20.8M | -60.88%20.73M |
| Current changes in cash | 17.52%-2.71M | 114.18%818K | 55.17%-10.7M | 65.47%-2.5M | 1,104.23%855K | 48.44%-3.29M | 44.13%-5.77M | -214.78%-23.87M | 5.80%-7.24M | 100.90%71K |
| End cash Position | -78.63%962K | -52.84%3.67M | -78.94%2.86M | -78.94%2.86M | -74.25%5.36M | -78.29%4.5M | -71.27%7.79M | -63.78%13.56M | -63.78%13.56M | -53.90%20.8M |
| Free cash flow | -9.79%-3.76M | 22.10%-4.45M | 49.14%-15.92M | 51.58%-3.46M | 56.12%-3.32M | 45.93%-3.42M | 44.28%-5.71M | -13.49%-31.3M | 6.89%-7.15M | 5.62%-7.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data